Compare BioNano Genomics Inc (BNGO) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Regeneron Pharmaceuticals Inc — how do they compare? BioNano Genomics Inc trades at $1.19 (market cap $13.66M), while Regeneron Pharmaceuticals Inc trades at $794.9 (market cap $82.06B). The key difference: Regeneron Pharmaceuticals Inc is far larger — about 6007.3× BioNano Genomics Inc's market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BNGO | REGN | |
|---|---|---|
Market Cap | $13.66M | $82.06B |
Sector | Health | Health |
52-Week High | $4.92 | $812.27 |
52-Week Low | $1.06 | $555.51 |
Enterprise Value | $16.26M | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
